Clinical Trials Logo

Clinical Trial Summary

This study will evaluate 3 doses of a new vaccine for rotavirus infection in healthy adult volunteers to determine if it is safe and if the immune systems of healthy adults respond to this vaccine.


Clinical Trial Description

The trial will be a double-blinded, randomized, placebo-controlled dose-escalation study in which three dose-levels of vaccine will be tested in adults. Cohorts of 16 individuals (12 vaccine recipients and 4 placebo recipients) per dose level will receive three intramuscular injections four weeks apart. The three dose levels of vaccine to test will be 10 microgram (μg), 30 μg and 60 μg. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01764256
Study type Interventional
Source PATH
Contact
Status Completed
Phase Phase 1
Start date December 2012
Completion date September 2013

See also
  Status Clinical Trial Phase
Completed NCT03207750 - This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Phase 3
Completed NCT00895492 - Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile N/A
Completed NCT01266850 - Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules Phase 4
Completed NCT02992197 - The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity Phase 4
Completed NCT00981877 - Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children N/A
Completed NCT05032391 - Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization Phase 3
Active, not recruiting NCT02662543 - The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines N/A
Completed NCT00302640 - Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children Phase 2/Phase 3
Active, not recruiting NCT04626856 - Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection Phase 1
Completed NCT00880698 - Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers Phase 2
Completed NCT01328925 - Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children Phase 2
Completed NCT00683982 - Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus N/A
Completed NCT01511133 - Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™ N/A